These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39025058)

  • 61. [Comparison of higher-dose haloperidol therapy with perazine standard therapy in acute schizophrenic patients].
    Schmidt LG; Schüssler G; Kappes CV; Müller-Oerlinghausen B
    Nervenarzt; 1982 Sep; 53(9):530-6. PubMed ID: 6127637
    [No Abstract]   [Full Text] [Related]  

  • 62. Experience with a drug-free month in schizophrenic outpatients.
    Heinrichs DW; Carpenter WT
    Psychopharmacol Bull; 1985; 21(1):117-9. PubMed ID: 2858904
    [No Abstract]   [Full Text] [Related]  

  • 63. [Treatment of schizophrenia: what the family doctor should know].
    Gruber O; Falkai P
    MMW Fortschr Med; 2008 May; 150 Suppl 2():16-9; quiz 20. PubMed ID: 18680837
    [No Abstract]   [Full Text] [Related]  

  • 64. Understanding schizophrenia: the impact of novel antipsychotics.
    Remington G
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S29-32. PubMed ID: 8564914
    [No Abstract]   [Full Text] [Related]  

  • 65. Factors associated with the prodromal progression of schizophrenia that influence the course of the illness.
    Bota RG; Sagduyu K; Munro JS
    CNS Spectr; 2005 Dec; 10(12):937-42. PubMed ID: 16344830
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effects of antipsychotic drugs and symptomatology on perceptual asymmetry in schizophrenia.
    Carr V; Wale J
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1531-7. PubMed ID: 2906089
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Longterm therapy of schizophrenia].
    Pajonk FG; Wobrock T; Falkai P
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
    [No Abstract]   [Full Text] [Related]  

  • 68. Cognitive behaviour therapy for schizophrenia: relationship between anxiety symptoms and therapy.
    Naeem F; Kingdon D; Turkington D
    Psychol Psychother; 2006 Jun; 79(Pt 2):153-64. PubMed ID: 16774715
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
    J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials.
    Sarin F; Wallin L; Widerlöv B
    Nord J Psychiatry; 2011 Jun; 65(3):162-74. PubMed ID: 21563994
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treating acute schizophrenic illnesses.
    Livingston M
    Practitioner; 1989 Feb; 233(1463):244-6. PubMed ID: 2573896
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An early phase II clinical trial of BW234U in the treatment of acute schizophrenia in newly admitted patients.
    Chouinard G; Annable L
    Psychopharmacology (Berl); 1984; 84(2):282-4. PubMed ID: 6150507
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
    Himelhoch S; Taylor SF; Goldman RS; Tandon R
    Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
    [No Abstract]   [Full Text] [Related]  

  • 74. Do negative symptoms respond to pharmacological treatment?
    Kane JM; Mayerhoff D
    Br J Psychiatry Suppl; 1989 Nov; (7):115-8. PubMed ID: 2575914
    [No Abstract]   [Full Text] [Related]  

  • 75. Managing acute exacerbations of schizophrenia: focus on quetiapine.
    Arango C; Bobes J
    Curr Med Res Opin; 2004 May; 20(5):619-26. PubMed ID: 15140327
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I; Levine S
    Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
    [No Abstract]   [Full Text] [Related]  

  • 77. Studies on the onset and time course of the effects of neuroleptics.
    Lipper S
    Am J Psychiatry; 1990 Jun; 147(6):814. PubMed ID: 1971498
    [No Abstract]   [Full Text] [Related]  

  • 78. Psychosocial treatments for schizophrenia.
    Liberman RP
    Psychiatry; 1994 May; 57(2):104-14. PubMed ID: 7938330
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophrenia.
    Bressan RA; Costa DC; Jones HM; Ell PJ; Pilowsky LS
    Schizophr Res; 2002 Jul; 56(1-2):31-6. PubMed ID: 12084417
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Management of schizophrenia with substance use disorders.
    Lybrand J; Caroff S
    Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.